Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a minor version update that does not alter the displayed study details.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's software revision label was updated from v3.6.4 to v3.6.5. This indicates a newer release of the page's underlying system rather than any substantive update to the study information.SummaryDifference0.0%

- Check53 days agoChange DetectedFooter revision label updated from Revision: v3.6.3 to Revision: v3.6.4, representing a minor update to the page's versioning metadata.SummaryDifference0.0%

- Check74 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing the previous v3.6.2, indicating a platform update. This reflects a software version change rather than a modification to study data or navigation elements.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page footer updated from revision v3.6.0 to v3.6.2. This reflects a small platform/template update rather than a substantive change to the study details.SummaryDifference0.0%

- Check95 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that participant enrollment is closed. Added user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the footer to Revision: v3.6.0, while replacing the label 'Intervention / Treatment' with 'Intervention/Treatment' and removing the previous revision 'v3.5.5'.SummaryDifference0.3%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.